what is known already: Vasectomy modifies the epididymal transcriptome and triggers non-reversible changes that affect sperm function. Some vasovasostomized men experience a reduced fertility outcome. study design, size, duration: Human epididymides provided by three control donors and three vasectomized donors were collected under artificial circulation through Transplant Quebec (Quebec, QC, Canada). Semen from three normal, three vasectomized and five vasovasostomized donors was provided by the andrology clinic.
Introduction
Surgical removal or occlusion of a portion of vas deferens (vasectomy) is a unique long-term and reliable method of male contraception. Historically, this procedure was developed for sterilization purposes and was not meant to be reversible. Today, vasectomy reversal surgery (vasovasostomy) is available to men who wish to start a new family. However, contrary to general belief, this surgery is sometimes nonreversible and fertility is often not restored. Indeed, following vasovasostomy, restoration of duct patency varies between 70 and 95% while pregnancy occurs in only 15-50% of the surgically successful cases (Feber and Ruiz, 1999; van Dongen et al., 2012) . Several sequelae may be responsible for the discrepancy between surgical success of vasovasostomy and pregnancy outcome, including local inflammation and granuloma formation (Flickinger et al., 1995) , presence of high titers of serum antisperm antibodies (Kay et al., 1993) , as well as molecular and biochemical changes that affect the male reproductive tract (Legare et al., 2010; Sullivan et al., 2011) .
The epididymis is a single long convoluted tubule that connects the testis to the vas deferens and is responsible for sperm maturation and storage (Bedford et al., 1973) . Gene expression is highly segmented throughout the different anatomical parts of this organ (i.e. caput, corpus and cauda) and tightly regulated by several factors including steroid hormones, lumicrine factors and small non-coding RNAs (Cornwall, 2009; Belleannée et al., 2012b) . This segmentation results in the formation of luminal microenvironments that sequentially modify maturing spermatozoa. Since the flux and composition of the intraluminal compartment is modified following vasectomy, the epididymis is subjected to sequelae that have consequences on sperm membrane composition, and possibly on sperm fertilizing ability. For instance, obstruction of the vas deferens under vasectomy modifies the gene expression profile throughout the human epididymis and the protein expression of DCXR/P34H, NPC2/HE1 and CRISP1/ AEGL1 that are present in epididymal fluid and play essential roles in sperm maturation (Thimon et al., 2008; Sullivan et al., 2011) . In some vasovasostomized men, we established that the epididymis is not able to recover from post-vasectomy sequelae . Therefore, these non-reversible epididymal defects might impair the capacity of spermatozoa to go through the major steps required to achieve the ability to fertilize and help to explain the discrepancy observed between surgical success rates and the subsequent pregnancy outcome following vasectomy reversal. However, molecular mechanisms behind this vasectomy-related infertility issue remain unknown. During the past decade, small non-coding RNAs such as microRNAs (miRNAs) have emerged as critical regulators of gene expression in a wide range of biological processes, including differentiation of the epididymal epithelium and acquisition of male fertility (Papaioannou et al., 2010; Hawkins et al., 2011; Bjorkgren et al., 2012) . These miRNAs consist of small RNAs ( 22 nucleotides) that regulate posttranscriptional gene expression by targeting mRNAs for cleavage or translational repression (Bartel, 2009) . In humans, we identified distinct miRNA signatures in caput, corpus and cauda epididymidis that correlate with the pattern of epididymal gene expression (Belleannée et al., 2012a) . Since gene expression is altered in the epididymis following vasectomy (Thimon et al., 2008) , we questioned the involvement of miRNAs in the post-vasectomy molecular changes occurring in the human epididymis.
Human seminal plasma is made up of a remarkable number of seminal microvesicles (SMVs) containing miRNAs provided from the different organs in the male reproductive tract. SMVs are heterogeneous and mainly consist in epididymosomes released by apocrine secretion from the epididymis, and prostasomes released by exocytosis from the prostate (Ronquist and Brody, 1985; Caballero et al., 2011) . In view of their significant number and their high stability in seminal plasma , SMVs containing miRNAs constitute an appropriate non-invasive tool to identify molecular changes originating from the epididymis. To identify molecular protagonists associated with post-vasectomy sequelae, we explored the consequences of vasectomy on the miRNA expression profile upstream (in the epididymis) and downstream (in SMVs) of the vasectomy site. By analyzing a unique set of human biological material from normal, vasectomized and vasovasostomized donors, our objective was to (i) portray miRNAs potentially involved in the modifications of gene and protein expression observed in the epididymis following vasectomy and (ii) identify reversible as well as non-reversible post-vasectomy miRNA sequelae that could have consequences on the decreased fertility outcomes reported after vasectomy reversal.
Materials and Methods

Ethical consent
Human epididymides were obtained from donors with no known pathologies that could potentially affect reproductive function-except vasectomy-through our local organ transplantation program (Transplant Quebec, QC, Canada) after obtaining written consent from the families. Semen was collected from the andrology clinic of our institution after obtaining written consent from the participants. Experiments performed in our study were in compliance with the Declaration of Helsinki and were conducted according to the policies for Human Studies with ethical approval from the Centre Hospitalier Universitaire's (CHUQ) Institutional Review Board.
Tissue and semen sample processing
Human epididymides from donors between 26 and 50 years of age were processed as previously described (Thimon et al., 2008) . Briefly, the testicles were removed under artificial circulation to preserve tissues assigned for transplantation and processed within 3 h. Vasectomy was determined during dissection of the scrotal segment of vas deferens. Epididymides from three normal control (26, 47 and 50 years old) and three vasectomized donors (45, 47 and 48 years old) were included in this study. Each epididymis was dissected in three segments corresponding to the caput, corpus and cauda regions and minced into small tissue pieces. Tissues were immediately snap frozen in liquid nitrogen for subsequent RNA extraction. All epididymides were obtained from Caucasian donors who had been vasectomized by closed-ended techniques; eliminating possible biases of open-ended versus closed-ended vasectomy and of racial background. Epididymides from vasovasostomized donors were not available during the 15-year collaboration with our local organ transplantation program.
Semen samples were obtained by masturbation from healthy volunteer control donors, as well as from vasectomized men and vasovasostomized men consulting for postsurgical spermogram follow-ups at our institution's clinical andrology laboratory. Between two and five days of sexual abstinence were required before semen collection. Control, vasectomized and vasovasostomized subjects were from the same reproductive age group.
Only semen samples from normal and vasovasostomized men that met the World Health Organization's reference values for semen analysis (1999) were included in our study. Once collected, samples were liquefied at room temperature and spermatozoa were pelleted and washed twice by centrifugation at 800 g in Dulbecco PBS. Seminal plasma was frozen at 2808C until used.
SMV preparation
SMVs were purified from seminal plasma using a method adapted from Fabiani et al. (1994) . Seminal plasma from normal, vasectomized and vasovasostomized donors was defrosted on ice and centrifuged at 4000 g for 20 min at 48C to remove cell debris. Resulting supernatants were pooled to obtain batches of seminal plasma from normal (n ¼ 3), vasectomized (n ¼ 3) and vasovasostomized donors (n ¼ 5). Pooled samples were centrifuged an additional time at 4000 g for 20 min at 48C and supernatants were ultracentrifuged at 120 000 g for 2 h at 48C. Pellets were resuspended in Tris 30 mM NaCl 130 mM, pH 7.5 and subjected to chromatography on Sephacryl S-500 HR (Pharmacia Canada Ltd, Dorval, QC, Canada) to purify membranous vesicles. Fractions containing SMVs were pooled and ultracentrifuged at 120 000 g for 2 h at 48C. Pellets were resuspended in PBS and stored at 2808C until use.
Total RNA extraction and miRNA purification Total RNAs were extracted from epididymal tissues with Trizol reagent (Invitrogen, Burlington, Canada) and purified by using RNeasy mini kit columns (Qiagen, Mississauga, Canada) as previously described (Thimon et al., 2008) . Sample quality was assessed on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) prior to miRNA microarray analysis. miRNAs from SMVs were extracted and purified by using a mirVana kit (Ambion, Life Technologies, Burlington, Canada) according to the manufacturer's recommendations and following enrichment procedures for small RNAs. Briefly, SMV suspensions were disrupted in lysis/binding buffer and subjected to organic extraction followed by a solid-phase extraction. miRNAs were eluted in 100 ml of RNase-free water, separated on Agilent 2100 Bioanalyzer and quantified using a Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA).
miRNA microarray analyses miRNA expression profiles from epididymal tissues and SMVs were processed by the Affimetrix microarray platform at the CHUQ Research Center (Quebec, Canada). All procedures were carried out according to the manufacturer's protocol as previously described (Belleannée et al., 2012a) . Briefly, 1 mg of total epididymal RNAs or 400 ng of SMV miRNA was labeled using FlashTag Biotin HSR (Genisphere, Hatfield, PA) and hybridized on GeneChip miRNA Array and GeneChip miRNA 2.0 Array (Affimetrix, Santa Clara, CA), respectively. GeneChip miRNA and GeneChip miRNA 2.0 probes are derived from the miRBase miRNA database v11 and v15, respectively (www.mirbase.org, last accessed 19 March 2013). Arrays were scanned on a GeneChip scanner 3000 G7 (Affymetrix), images were processed with miRNA QC Tool software for quality control and CEL files were analyzed with the Partek Genomics Suite 6.5 software (Partek Incorporated, St Louis, MO).
Statistical analyses
miRNA microarrays from total RNA extracts of epididymal tissues and from small RNAs enriched from SMVs were subjected to background subtraction by using robust multi-array analysis (RMA) and logarithmic transformation. A threshold was applied to normalized data and excluded miRNAs whose intensity values were lower than the median of dataset expression matrix, which is 3.2 and 2.0 for epididymal and SMV samples, respectively. Epididymal miRNA profiles from three normal and three vasectomized donors were compared by ANOVA with different contrasting factors by using the Partek Genomics Suite 6.5 software. Significant miRNA changes were selected based on the following criteria: (i) statistical significance-miRNA expression changes were identified using a P-value threshold of 0.01; and (ii) fold change expression-a minimum 1.5-fold difference in either direction was required. An unsupervised clustering algorithm was applied to differentially expressed miRNAs.
SMV miRNA signatures were determined in normal, vasectomized and vasovasostomized donors from pooled miRNA samples in order to overcome several surgical variables (i.e. donor age, time elapsed between vasectomy and vasectomy reversal surgery, time elapsed after vasovasostomy) that could interfere with SMV miRNA profiles. In this case, inter-individual variability was not taken into account and only miRNAs exhibiting a minimal 1.5-fold difference between the different groups were selected.
miRNA target prediction and integrated analysis of expression profiles
Potential mRNA targets of differentially expressed miRNAs and integrated analysis of epididymal miRNAs/mRNAs expression profiles were predicted by using MAGIA software (http://gencomp.bio.unipd.it/magia/ start/, last accessed 19 March 2013). Three algorithms were included in our analysis for target prediction: TargetScan, MiRanda and Pita. Only targets that were found with these three algorithms were considered. Based on these target predictions, miRNA datasets were compared with gene expression profiles obtained previously from the same biological samples (Thimon et al., 2008) . Correlation between miRNAs and their target gene expression was measured by using a non-parametric rankbased Spearman correlation. miRNA-correlated genes were sorted into representative biological function groups by Partek Gene Ontology (GO) analysis from the Partek Genomics Suite 6.5 software.
Real-time PCR on selected miRNAs
A real-time PCR method adapted from Varkonyi-Gasic and Hellens (2010) was used to validate differentially expressed SMV miRNAs, as previously described (Belleannée et al., 2012a) . Pulsed reverse transcription was performed after denaturation of 300 ng of SMV miRNAs extracts, 62.5 mM of each dNTP and 50 nM of the stem-loop primer at 658C for 5 min. FirstStrand buffer, 10 mM DTT, 4 units of Protector RNAse Inhibitor (Roche, Laval, QC, Canada) and 50 units of SuperScript III RT (Life Technologies Inc., Burlington, ON, Canada) were added to the mix for a total reaction volume of 20 ml. Reactions were placed on a MJ Mini thermal cycler (Biorad, Hercules, CA, Canada) and incubated for 30 min at 168C, followed by pulsed reverse transcription of 60 cycles at 308C for 30 s, 428C for 30 s and 508C for 1 s. Real-time PCR was performed by using SYBR Green assay on a Light Cycler (Roche, Laval, QC, Canada) according to manufacturer's instructions. Briefly, 2 ml of reverse transcription templates as well as no template negative control were mixed with SYBR Green I Master Mix in addition to 0.5 mM of each primer for a total volume of 20 ml, and placed in capillary tubes. Samples were incubated at 958C for 5 min, followed by 40 cycles of 958C for 5 s and 608C for 10 s. Fluorescence signals were continuously acquired at 530 nm from 658C to 958C at 0.28C per second. Duplicate reactions were performed three times. For each miRNA, a standard curve containing four points was plotted. Data were normalized to hsa-Let-7b miRNA. Primers used in this study are listed in Supplementary data, We identified 336 and 394 miRNAs expressed in the epididymis of normal and vasectomized donors, respectively (Fig. 1A , Supplementary data, Table SII). As previously described (Belleannée et al., 2012a) , the pattern of miRNA expression is segmented in different regions of the epididymis from normal donors. Indeed, 16% of epididymal miRNAs found in normal donors are specifically expressed in caput, corpus or cauda epididymidis, while 70% of miRNAs are expressed throughout the epididymis (Fig. 1A , Supplementary data, Table SII ). This segmentation is maintained following vasectomy, with 27% of epididymal miRNAs specifically expressed in caput, corpus or cauda epididymidis and 66% expressed throughout the epididymis. Despite the maintenance of a segmented miRNA expression profile, we observed substantial changes in the miRNA signature from distinct epididymal segments following vasectomy ( Fig. 1A and B, Supplementary data, Table SII ). While expression of 94% (222/234) of miRNAs found throughout the epididymis from normal donors was not affected by vasectomy, most of miRNAs exclusively expressed in specific regions exhibited a shut down or a delocalization of their expression (Fig. 1B) . Major changes were observed in cauda epididymidis with 61% (17/28) of cauda miRNAs not found in the epididymis of vasectomized donors. Conversely, 71 miRNAs were detected only in cauda epididymidis from vasectomized donors.
The statistical significance of miRNA expression changes occurring after vasectomy was assessed by analysis of variance. We demonstrated that vasectomy significantly alters miRNA expression in each anatomical region (fold change .1.5 or ,21.5, P-value , 0.01) (Fig. 1C) . For instance, we identified four (miR-126, miR-129, miR-326 and miR-16) , two (miR-1826 and miR-18a) and nine miRNAs (miR-941, miR-548b, miR-1826, miR-1281, miR-1825, miR-548c, miR-1278, miR-421 and miR-135a) whose expression significantly varied post-vasectomy in caput, corpus and cauda epididymidis, respectively (Fig. 1C) . Overall, vasectomy strongly affects the miRNA signature of the whole epididymis and mainly triggers a decrease of miRNA expression, with 22 miRNAs significantly down-regulated following vasectomy versus 8 miRNAs significantly up-regulated (Fig. 1C and Table I ).
Correlation between epididymal miRNA expression and predicted mRNA targets altered by vasectomy Integrated analysis of miRNA and mRNA expression profiles was carried out on the same epididymal samples from three normal and three vasectomized donors and identified significant miRNA-mRNA correlations. In our global analysis, 274 miRNA:mRNA pairs exhibited a correlation in expression across the epididymis (Supplementary data, Table SIII), including 149 miRNAs:mRNA negatively correlated pairs (Spearman's correlation below 20.50) and 125 miRNAs:mRNA positively correlated pairs (Spearman's correlation above 0.50). Among the strongest and most statistically significant negative correlations, we identified miR-941:Herc1, miR-941:Plglb2, miR-1825:Insr, miR-491-5p: Gsdmb, miR-491-5p:Pdpr and miR-298:CD40 (Fig. 2) . In contrast, miR-423-3p:Psph, miR-423-3p:C19orf66, miR-557:Tnrc18, miR-885-3p: Stk11, miR-423-3p:Traf7 and miR-125b:Aqp9 were significantly and positively correlated (Fig. 2) . According to GO term categories generated from the set of miRNA-correlated genes, most mRNAs predicted to be regulated by epididymal miRNAs belong to categories of nucleic acid (34%) and protein binding (31%) transcription factors as well as receptors (21%)(Data not shown).
Identification of reversible and non-reversible post-vasectomy miRNA sequelae in SMVs miRNAs shuttled by SMVs in seminal plasma are potent non-invasive biomarkers to evaluate defects originating from the different organs of the male reproductive tract, including the epididymis (Wang et al., 2011) . In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV ). Most of these miRNAs (84%) were found in the three types of samples. Despite modest qualitative differences between these samples, important modifications were observed at the quantitative level with miRNA fold changes ranging from 228.6 to 84.2 between sample groups (Supplementary data, Table SV ). For instance, vasectomy modified the expression of 118 SMV miRNAs (38%) with a fold change below 21.5 or above 1.5 compared with normal donors.
Among miRNAs detected in SMVs, 20 and 32 miRNAs were, respectively, more and less abundant in SMVs from vasectomized donors relative to normal control donors and had a tendency to return to normal values following vasectomy reversal (Table II) . These 52 miRNAs were, therefore, qualified as reversible postvasectomy miRNA sequelae. In contrast, 21 and 45 miRNAs were, respectively, more and less abundant in SMVs from vasectomized donors relative to normal control donors but their expression did not return to normal values following vasectomy reversal (Table II) . Therefore, these miRNAs are most likely non-reversible postvasectomy miRNA sequelae. By real-time PCR, we determined the expression of miR-26b, miR-202, miR-892b, miR-890 and miR-181b belonging to the category of reversible post-vasectomy sequelae, as well as miR-34c-3p and miR-509-5p belonging to the category of potential non-reversible post-vasectomy sequelae in the different SMV samples (Fig. 4) miR-892b and miR-181b was consistently very high in SMVs from normal and vasovasostomized donors relative to SMVs from vasectomized donors in which these miRNAs were barely detectable. The opposite effect was observed by microarray and confirmed by real-time PCR for miR-26b, whose expression was enhanced in SMVs from vasectomized donors and drastically decreased to normal intensity after vasectomy reversal. We also confirmed that miR-202, miR-34c-3p and miR-509-5p are strongly affected by vasectomy and their presence in SMVs is only partially retrieved after vasectomy reversal (Fig. 4) .
Identification of SMV miRNAs provided by the epididymis: the contribution of epididymosomes
Vasectomy prevents spermatozoa and epididymal fluid containing epididymosomes from reaching the vas deferens. Since SMVs found in the seminal plasma of vasectomized donors are devoid of miRNAs originating from the epididymis, we assessed the contribution of epididymosomal miRNAs to the miRNA signature of SMVs. In SMVs, 18 miRNAs (6%) were exclusively found in normal and vasovasostomized donors and absent in vasectomized donors, suggesting that these miRNAs originate from the epididymis (Fig. 3 , Table III ). Published experimental data corroborate the epididymal origin of some of these miRNAs. For instance, miR-888, miR-891b, miR-892a and miR-892b belonging to the miR-888 cluster are specifically expressed in the corpus and cauda regions of the human epididymis (Landgraf et al., 2007; Belleannée et al., 2012a) . In addition, results streaming from epididymal and SMV miRNA microarray analyses indicated that vasectomy altered the expression of 18 miRNAs in both the epididymis and SMVs (Supplementary data, Table SV ). For example, expression of miR-574-5p decreased both in the cauda epididymidis and in SMVs and was recovered following duct patency retrieval, suggesting that this miRNA originates from the epididymal fluid. This indicates a dual effect of vasectomy on miR-574-5p: (i) according to epididymal miRNA data, vasectomy alters miR-574-5p expression level upstream of the obstruction site and (ii) vasectomy blocks the release of epididymal fluid containing miR-574-5p into the seminal plasma, therefore impacting the area downstream of the obstruction site. These results suggest that several miRNAs of epididymal origin, including miR-574-5p, are released into the epididymal fluid via epididymosomes and might be used to diagnose epididymal-related disorders.
Discussion miRNAs are small non-coding RNAs generated from miRNA precursors that need to be processed by the endonuclease Dicer to become functional. These mature miRNAs control gene expression and are considered to play important roles in numerous cellular processes including development, differentiation, apoptosis and cell proliferation (Bartel, 2009 ). In the epididymis, impairment of miRNA biogenesis following Dicer1 depletion in proximal regions of the organ triggers dedifferentiation of the epithelium and failure to generate offspring (Bjorkgren et al., 2012) . This illustrates the importance of miRNAs on the physiology of the epididymis, the organ in charge of sperm maturation. In our study, we demonstrated that the miRNA profile was strongly modified following vasectomy in the human epididymis, and could therefore be implicated in mediating the molecular and biochemical changes that affect the human male reproductive tract after such surgery (Thimon et al., 2008; Legare et al., 2010; Sullivan et al., 2011) . After vasectomy, the portion of the vas deferens that is located upstream of the obstruction site is subjected to an increase in pressure and tubular distention that can result in leakage of spermatozoa and in the formation of epididymal granuloma (Adams and Wald, 2009 ). The distal region of the epididymis may be affected by these disruptions which will most likely induce cellular responses involving miRNAdependent regulations. We demonstrated that the cauda epididymidis is the region whose miRNA expression profile is the most responsive to vasectomy, which is also the case for gene expression (Thimon et al., 2008) . For instance, the pattern of 9 miRNAs is significantly altered in the human cauda epididymidis following vasectomy (P , 0.01, fold change .1.5 or , 1.5), including miR-421, miR-135a and miR-941, which are involved in inflammatory response (Marchand et al., 2012) , cell proliferation (Piriyapongsa and Jordan, 2007) and cell differentiation (Hu et al., 2012) , respectively. While the targets and functional roles of these miRNAs in the epididymis have not been described so far, the fact that one miRNA can target several thousand mRNAs (Bartel, 2009 ) implies a profound impact of the miRNA deregulation on the physiological functions of the epididymis. We conducted an integrated study by combining the previously published transcriptomic data from three epididymal regions of three normal and three vasectomized donors (Thimon et al., 2008) , with the corresponding miRNA profiles from the same samples. For instance, we demonstrated that Herc1 (Probable E3 ubiquitin-protein ligase) and Rassf2 (Ras association domain-containing protein 2) are two genes related to the proteasomal degradation/ubiquitination pathway (Garcia-Gonzalo et al., 2003; Cooper et al., 2009 ), whose expression is increased following vasectomy and significantly negatively ..................................................................................................................................................................................... 
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Vasectomy initiates non-reversible miRNA changes correlated with miR-941 and miR-193b, respectively. Another gene encoding for GSDMB (Gasdermin B) induced after vasectomy and known to regulate the secretory pathway of epithelial cells (Carl-McGrath et al., 2008) is negatively correlated with miR-491-5p. Interestingly, both ubiquitination and protein secretion are important epididymal functions that ensure proper sperm maturation in the epididymis (Cooper, 1998; Dacheux et al., 2006; Bedard et al., 2011) . Therefore, deregulation of these functions by miRNAs following vasectomy might have an impact on the sperm's fertilizing ability in vasovasostomized men.
Because few human epididymides become available, reversibility of post-vasectomy sequelae in this organ is difficult to explore. Since seminal plasma contains many molecules-including miRNAs-that are secreted from different organs in the male reproductive tract, and can be used to diagnose male reproductive system disorders (Wang et al., 2011) , we hypothesized that miRNAs contained in SMVs are non-invasive markers of epididymal post-vasectomy sequelae that could help assess their reversibility. Vasectomy initiates non-reversible miRNA changes donors, we identified 66 non-reversible and 52 reversible miRNA sequelae in SMVs. Our study suggests that miR-34c, miR-509-5p and miR-122 and miR-513a-5p might be considered as non-reversible miRNA post-vasectomy sequelae (Table II) . However, the response of these miRNAs to vasectomy will have to be investigated on larger cohorts with different delays between vasectomy and vasovasostomy in order to confirm their absolute non-reversibility. Interestingly, these miRNAs have recently been identified in seminal plasma as potential markers of male infertility (Wang et al., 2011) and their expression may, therefore, be linked to an unfavorable fertility outcome occurring after vasovasostomy. In addition, direct correlation between candidate miRNAs in the semen of vasovasostomized individuals and fertility outcome remains to be determined in order to develop predictive markers of vasovasostomy success. Vasectomy prevents spermatozoa and epididymal fluid containing epididymosomes from reaching the vas deferens. We demonstrated that some miRNAs detected in human epididymides were also present in SMVs from normal and vasovasostomized donors but absent in SMVs from vasectomized donors. These miRNAs are therefore not only expressed in the epididymis but also released into the epididymal fluid via microvesicles, most likely epididymosomes, whose contribution to seminal plasma is prevented by vasectomy. While the role of epididymosomes in protein transfer to the sperm membrane is well acknowledged, this study is the first to document their capacity to vehicle miRNAs. Among these miRNAs, miRNAs belonging to the miR-888 cluster (i.e. miR-890, miR-891b, miR-892a and miR-892b) are abundant in SMVs. Interestingly, these miRNAs are specifically expressed in the epididymis of non-human and human primates, and have been predicted to regulate proteins involved in sperm maturation (Li et al., 2010) . Since the miR-888 cluster is predominantly expressed in the human epididymis (Landgraf et al., 2007; Belleannée et al., 2012a) and contained in SMVs-most likely in epididymosomes-these miRNAs constitute potential noninvasive seminal biomarkers for the diagnosis of epididymis-related infertility issues and may be used as predictive markers of vasovasostomy success.
In conclusion, we identified several miRNAs whose expression was greatly modified in both the epididymis and SMVs from the seminal plasma of vasectomized individuals. According to our integrated study, these sequelae may alter essential functions that ensure proper sperm maturation and that regulate the sperm's fertilizing ability. Identification of post-vasectomy miRNA sequelae in SMVs provides substantial information regarding the molecular mechanisms that could affect fertility outcomes following a vasectomy reversal and might provide new tools for the prediction of vasovasostomy success and contribute to a better understanding of male infertility.
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